PDL BioPharma, Inc. Remaining Share Repurchase Authorization
PDL BioPharma, Inc. had Remaining Share Repurchase Authorization of $25.00 million as of 2018-05-08, per its 10-Q filed 2018-08-09.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2018-08-09
- 2018-05-08: Stock Repurchase Program, Remaining Authorized Repurchase Amount $25.00M; Stock Repurchase Program, Remaining Authorized Repurchase Amount as first filed $12.40M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount | Stock Repurchase Program, Remaining Authorized Repurchase Amount as first filed |
|---|---|---|
| 2018-05-08 | $25.00M 10-Q · filed 2018-08-09 | $12.40M 10-Q · filed 2018-05-09 |